BioSpace News Archive

Business

The Committee of prominent health researchers and Nobel laureates renames the Prix Galien Pro Bono Humanum Award to recognize the global health leadership of Dr. Roy Vagelos

The Prix Galien USA Committee announced today that the Prix Galien Pro Bono Humanum Award for individual service to improve the state of human health will be renamed in honor of Dr. P. Roy Vagelos, Retired Chairman and CEO, Merck & Co., Inc. Chairman of the Board, Regeneron Pharmaceuticals.

June 14, 2018
·
5 min read
Business

Avelas Biosciences to Present at JMP Securities Annual Life Sciences Conference

Avelas Biosciences, Inc. announced that Carmine N. Stengone, President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference

June 14, 2018
·
1 min read
Business

HSS Hip and Knee Surgeon Bradford Waddell, MD, Named Chair of Young Arthroplasty Group

Dr. Waddell Co-Founded New Group within AAHKS

June 14, 2018
·
3 min read
Genetown

Medrobotics® Announces $25MM Venture Debt Investment Commitment from Western Technology Investment

Company Plans to Drive Additional Growth by Extending the Reach of the Flex® Robotic System and Expanding its Manufacturing Capacity.

June 14, 2018
·
1 min read
Policy

WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the “MAH” Pilot

WuXi STA enables Ascletis to receive NDA Approval from China FDA for Ganovo (R)

June 14, 2018
·
3 min read
Drug Development

Genentech Announces New OCREVUS (Ocrelizumab) Data on Long-Term Disability Benefits in Primary Progressive Multiple Sclerosis and Initiation of Two Global Studies in Progressive MS

Genentech announced today that new OCREVUS® (ocrelizumab) data will be presented at the 4th Congress of the European Academy of Neurology.

June 14, 2018
·
16 min read
Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge

Avrum Spira, Global Head, Lung Cancer Initiative, Johnson & Johnson, and Melinda Richter, Global Head, Johnson & Johnson Innovation, JLABS, made the announcement at CES Asia in Shanghai, China.

June 14, 2018
·
2 min read
Drug Development

Verseon to Initiate Phase I Study to Evaluate a New Precision Oral Anticoagulant with Reduced Bleeding Risk

First-in-human phase I trial in Australia for its lead-PROAC VE-1902, which has successfully completed regulatory toxicology studies and was well-tolerated in 28-day repeat dosing.

June 14, 2018
·
3 min read
Business

Cheetah Medical’s French Distributor SEBAC SA to Supply Starling SV Monitoring Systems to Paris’ Public Hospital System

The four-year deal calls for the Starling SV Hemodynamic Monitoring System to be installed in more than 40 hospitals around Greater Paris.

June 14, 2018
·
3 min read
Drug Development

Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy

Phase 1/2 clinical trial in patients with advanced solid tumors that have progressed on anti-PD-1/PD-L1 therapy to evaluate APX005M in combination with cabiralizumab and Opdivo

June 14, 2018
·
3 min read